Component profile in the metabolic syndrome of diabetic patients received fixed dose combination of glibenclamide and metformin before and after treatment
摘要：
Background DLBS3233, a combined bioactive fraction of Methods This was an open and prospective clinical study for 12 weeks of therapy, involving type-2 diabetes mellitus patients who had been treated with two oral antidiabetic agents for at least 3 months prior to screening, yet, with HbA Results After 12 weeks of treatment, the HbA Conclusions The add-on oral antidiabetes therapy with...
展开
会议名称：
Surabaya Metabolic Syndrome Update (SUMETSU) VII
会议时间：
2011/02/12
ResearchGate
penelitian.unair.ac.id
(全网免费下载)
penelitian.unair.ac.id
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
请先登入
相似文献
参考文献
引证文献
来源会议
站内活动
辅助模式
0
引用
文献可以批量引用啦~
欢迎点我试用！
